Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $40,003 - $45,501
-963 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $7,528 - $8,249
161 Added 20.07%
963 $45,000
Q2 2017

Aug 14, 2017

BUY
N/A
802
802 $34,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Natixis Investment Managers International Portfolio

Follow Natixis Investment Managers International and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.